Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast Cancer.
about
Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysisTargeted therapies in breast cancer: New challenges to fight against resistance.PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian PatientsTRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysisEfficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug.Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.Meta-analysis of the prognostic value of p-4EBP1 in human malignancies.High expression of LAMP2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.Expression of pAkt is associated with a poor prognosis in Chinese women with invasive ductal breast cancer.Magneto-chemotherapy for cervical cancer treatment with camptothecin loaded Fe3O4 functionalized β-cyclodextrin nanovehicle
P2860
Q36190276-D3295035-C284-415C-9757-AF2CB7FDB11CQ37743048-A16F0763-9156-4D02-9FA8-588211C6262FQ38752902-4B9A1ED8-0776-47A8-8913-397F57308C4BQ41144441-0DC133D1-A660-45D3-9C23-DEC005D151D9Q41477504-C5955B1E-CBF9-4E66-B606-3522A0B36194Q42078197-878A7EBA-9E63-4CC8-AAF8-A0E8EB1E7AB2Q49515435-CEC64FA7-5099-4539-A381-FDDF95CF0F63Q51029917-C152BFA5-9D08-4DDE-8094-17ED1CEC9134Q52649756-6632A75A-C5ED-49AA-91EC-DFFC3E7C53BEQ58949768-188D35B9-B9F7-44D3-B185-8AC26CD9BC18
P2860
Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@ast
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@en
type
label
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@ast
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@en
prefLabel
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@ast
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@en
P2093
P2860
P1476
Analysis of PI3K/mTOR Pathway ...... -Negative Early Breast Cancer.
@en
P2093
Hamdy A Azim
Isabelle Treilleux
Loay Kassem
Mona Abu El Enein
Shady E Anis
Thomas Bachelot
P2860
P304
P356
10.1016/J.TRANON.2016.01.001
P577
2016-04-01T00:00:00Z